Background. Children with giant congenital melanocytic nevi (GCMN) pose a great challenge to pediatric and reconstructive surgeons because they have to cover the widely exposed area after its excision. A variety of treatment options exist for the management of such cases. In this retrospective review of a selected group of children who had a GCMN of their abdominal walls managed with implantation of tissue expanders (TEs) for staged reconstruction, patients were evaluated with respect to complications and general and esthetic criteria for patient and parent satisfaction. Objective. The purpose was to study the feasibility of use of TEs in the management of children who had GCMN, with special emphasis on the complications and children's and parents' satisfaction. Material and methods. Retrospective data from the 12 patients' charts, operative data of 86 surgical procedures, and follow up visits were analyzed using the Student's t test, and P < .05 was considered statistically significant. Results. In a period of 4 years, from 2004 to 2008, the results of using 37 different sizes of TEs and 86 operative procedures in 12 children (9 boys and 3 girls) aged from 2 to 12 years with different types of abdominal wall GCMN are discussed. Conclusion. The TE is a useful and feasible tool for reconstruction of the abdominal wall in cases of GCMN in children. Parents and children are satisfied in general and also with the body image.
Introduction
Congenital melanocytic nevi occur in approximately 1% of newborns. But giant congenital nevi occur in 1 in 1000 to 1 in 20 000 newborns. They are usually classified according to their size: giant nevi are most simply defined as melanocytic nevi that are greater than 20 cm in their largest dimension, whereas small congenital nevi are defined as melanocytic nevi less that 1.5 cm in their largest dimension. Garment nevi involve a very large body surface area, for example, the entire back or an extremity, and occur in 1 in 500 000 newborns. 1 In this study, we adopted the definition of GCMN proposed by Bittencourt et al, 2 where lesions measuring at least 20 cm in largest diameter in adults or lesions predicted to reach 20 cm in largest diameter by adulthood are considered giant. Congenital nevi can exhibit distinctive histological features that can help in differentiating them from common acquired nevi. GCMN are associated with an increased risk of the development of melanoma. The frequency of malignant transformation in congenital nevi has been estimated to be between 2% and 20%, although an incidence of 5% was reported in a prospectively followed series of 80 children. 3 Many treatment options have been postulated for giant CMN, including dermabrasion, CO 2 laser ablation, phenol chemical peels, curettage, excision and skin grafting, use of expanded full thickness skin grafts, serial excision, tissue expansion, and free tissue transfer. 4 Our practice has been one of surgical excision after staged tissue expansion, and the final goals are reduction and control of symptoms, aesthetic improvement, psychosocial well-being, maintenance of function, and decrease in the risk of malignant degeneration.
Materials and Methods
The medical records and operative reports of all patients were analyzed. Each patient was studied with respect to indication for the procedure; location, shape, volume, and dimensions of the expander; previous expansion if any; and complications. The data were analyzed for frequencies and percentages and to determine the possible correlation between the complications and the factors studied.
Overview of Our Protocol of Management
MRI of the central nervous system was done for all patients in this study to rule out any central nervous system involvement by melanocytic tissue because magnetic resonance findings of neurocutaneous melanosis are relatively common, even in asymptomatic children with GCMN. 5 Preoperatively, all patients were evaluated by psychotherapists and social workers and were premedicated with oral midazolam. Postoperative paracetamol supplements were considered for analgesia.
Under general anesthesia, tissue expanders (TEs) were inserted at the edge of the melanoma, very close to the line of the junction between normal and affected skin. The implant was initially filled at surgery to a comfortable size, and we considered that the overfilling of the implant would then overcome slight irregularities in the contour that may have been created by the internal capsulodesis itself. Subsequent filling was done at weekly intervals in the outpatient clinic after parental education but sometimes twice a week if there were any complications.
The TEs were removed under general anesthesia and a capsulotomy performed, scoring the capsule radially and transversely to allow additional advancement of the expanded tissue. Maximal excision of the abdominal wall GCMN was carried out, and the newly expanded skin was advanced to fill the defect. After a 3-to 6-month recovery and scar maturation period, the patient was reassessed for second-stage expansion, and the procedure was repeated if necessary.
Different types of sutures such as polyproline, vicryl, and skin staplers were used without any significant difference in the scar thickness ( Figures 1 and 2 ). If the margins of the lesion are still not clear after a 3-staged serial excision, a fourth-stage excision may be warranted. All melanocytic tissues that were removed were studied histopathologically and by immunohistochemistry.
A questionnaire was designed to evaluate parents' and children's satisfaction, and 10 points were evaluated (body image, umbilical position, wound scars, remaining nevi, complications, postoperative analgesia, inflation pain, hospital stay, outpatient visits, and investigations). Each point was given a score from 0 to 3 (0 = unsatisfied; 1 = mild satisfaction; 2 = moderate satisfaction; 3 = good satisfaction). Parents were the main target for scoring in patients aged 7 years and younger, but the child's opinion was considered from the age of 7 years. The total scores for every patient and every point in the comparisons between patients were deliberated.
Results
In a period of 4 years, from 2004 to 2008, 12 children (9 boys and 3 girls) aged from 2 to 12 years (median age range: = 6.5 years) had GCMNs ranging from 17 to 35 cm (median, range: 22 cm) in their largest diameter in their abdominal wall. They were enrolled in this study, and 37 different sizes of TEs were implanted through 86 operative procedures (Table 1 ). No patient in this study had any manifestation or MRI sign suggestive of neurological involvement, and all excised specimens were sent for histopathological and immunohistochemical studies. None of them had any melanotic changes. Two cases showed woolly nevi at the lumbar regions. The interval between each surgical procedure was between 3 and 7 months (mean 4 months). The number of TEs inserted per patient ranged from 2 to 5. The total number of expanders used were 37 (median = 3). The TEs used were mainly circular followed by oval; rectangular ones were used only in 2 procedures ( Table 2) .
Complications
Major complications were identified in 7 out of 37 placed expanders (19%). These included the following: TE exposure in 1 case, which necessitated reimplantation (2.7%); 3 cases of infections (8%); and 3 expander failures (8%), of which 1 was port failure.
Minor complications were hematoma in 1 patient (2.7%), which resolved with conservative measures; 2 cases developed seroma around the TE (5.4%), which was aspirated, and a compression bandage was applied; and 2 cases developed partial suture dehiscence (5.4%), which was managed by 2ry sutures. There were no keloid scars in these patients, but hypertrophied scars developed in 2 patients and were treated by local corticosteroid application. There was no significant correlation between age and the rate of complications (P > .05; Table 3 and Figure 3 ).
Patient Satisfaction
Satisfaction was tested in this group of patients for 10 items, and each one was given a score from 0 to 3. The overall satisfaction score ranged from 23 to 29 (median 26) out of 30 points scored; 58% of the patients had a good satisfaction rate, 34% moderate, and 8% mild. Also, all patients had a higher satisfaction rate for their body image, and they were satisfied with the way investigations were conducted (34 out of 36); the lowest satisfaction rate was for the complication rate (28). See Tables 4 and 5 and Figure 4 . 
Discussion
TEs have been of great value in reconstructive surgery during the past 2 decades. Tissue expansion was developed for a specific indication; however, within a very short time, this concept has found wide applicability ( Figures 5 and 6 ). 5 Cutaneous expansion is used increasingly in reconstructive surgery for the treatment of a variety of problems in children and adults. In 1956, Neumann and Charles 6 were the first to recognize the potential of tissue expansion for reconstructive surgery. They implanted a balloon beneath the temporal region for reconstruction of an absent ear. In 1976, Radovan 7 used the TE concept for reconstruction of the breast after mastectomy. Subsequently, the use of tissue expansion has been popularized among plastic surgeons and has become the treatment method of choice for many congenital and acquired defects in a wide variety of diseases in adults and then later in children. 8 TE are silicone envelopes that have self-sealing injection ports, which are injected at weekly or more than weekly intervals; saline is progressively injected through the port and passes into the expander, which enlarges. As the volume inside the implant increases, tension placed on the overlying and adjacent tissues increases.
The expanded skin undergoes histological changes that are well documented: the epidermis exhibits increased mitotic activity; there is recruitment of adjacent tissue, which is believed to contribute to the additional skin; and the dermis thins considerably, but it is often masked clinically by the thick fibrous capsule that forms around the implant. 9 Skin expansion allows the surgeon to generate additional amounts of precious tissue, to thin the flap, and to increase its vascularity. 10 The overall complication rates reported with the use of TE in the literature vary widely, ranging from 13% to 40%, 8 but the complication rates in pediatric patients range from 9% to 37%. 11 Management of children with GCMN poses great challenges to the treating surgeon because he or she has to excise the melanocytic tissues completely and then replace the widely exposed vicinity with a proper skin matching the contiguous skin. 12 With proper treatment, patients and their families can expect a decreased risk of melanoma with the possibility of early detection and cure of melanoma, amelioration of symptoms, improved aesthetics with associated psychosocial stability, and maintenance of function. 13 After 1989, operations tended to use multimodality treatment plans, with an increased use of expanded fullthickness grafts and immediate serial tissue expansion. The use of serial excision, particularly in the extremities, also increased after 1989. Serial excision was the treatment of choice when it could be completed in 2 procedures or less, which occurred in more than 80% of cases using serial excision alone. Serial excision was the most common form of treatment in the extremities. Tissue expansion was frequently used to provide expanded fullthickness skin grafts harvested from the torso. 14 
Research on both adult patients and parents of pediatric
patients has demonstrated that satisfaction with medical encounters predicts important outcomes such as compliance with the medical regimen. 15 On the basis of these data, algorithms for the extent of resection and subsequent reconstructive options for giant congenital nevi were developed. Their management should be formulated relative to pigmentation, malignant potential, and anatomic location of the respective lesions. Several authors advocate ablative methods such as laser excision, chemical peels, and dermabrasion for the management of giant CMN. 16 However, if it could be anticipated that 4 or more stages would be required to remove a lesion in its entirety, tissue expansion should be the initial treatment of choice.
In this study, the overall number of complications was 7, out of the total 37 placed TEs (19%); this could be taken to be 8% if we account for the fact that the total number of procedures was 86. Major complication like TE exposure occurred in 1 case, which necessitated reimplantation (2.7%); there were also 3 cases of infections (8%) and 3 expander failures (8%) of which 1 was a port failure. Minor complications were hematoma in 1 patient (2.7%), which resolved by conservative measures; 2 cases developed seroma around the TE (5.4%), which was aspirated, and a compression bandage was applied; and 2 cases of partial suture dehiscence (5.4%) were managed by 2ry sutures. No keloid scars were encountered in these patients, but hypertrophied scars developed in 2 patients and were treated by local corticosteroid application. There was no significant correlation between age and complications (P > .05).
Patient satisfaction was tested in this group of patients for 10 items, and each one was given scores from 0 to 3. The overall satisfaction score ranged from 23 to 29 (median 26) out of 30 points scored; 58% of the patients had a good satisfaction rate, 34% moderate, and 8% mild. Also, all patients had a higher satisfaction rate for their body image, and they were satisfied with the way in which investigations were conducted; the lowest satisfaction rate was for the complication rate.
From this study, we conclude that TEs are a useful and feasible tool for the management of GCMN in children with acceptable patient satisfaction and an acceptable rate of complications.
